摘要
目的分析注射用头孢哌酮钠/舒巴坦钠不良反应发生情况,为临床合理用药提供参考。方法对国内2000年1月～2006年12月公开发表的注射用头孢哌酮钠/舒巴坦钠出现的59例不良反应报道进行整理、归纳和分析。结果注射用头孢哌酮钠/舒巴坦钠导致变态反应的案例比较常见。结论临床应加强对注射用头孢哌酮钠/舒巴坦钠不良反应的预防和监测。
Objective To summarize Adverse Drug Reaction（ADR）of cefoperazone sodium and sulbacram sodium for injection, prove information for rational usage of it in the clinical. Methods Fiftynine case reports on ADR of cefoperazone sodium and sulbactam sodium for injection ranging from January 2000 to December 2006 were collected by statistically classified and analyzed. Results The all- ergic reaction was most common in the case reports on ADR of cefoperazone sodium and sulbactam sodium for injection, Conclusion At-tendon should be paid to ADR ofcefoperazone sodium and sulbactam sodium for injection to ensure safe and rational drug use.
出处
《中国药物警戒》
2007年第5期285-288,共4页
Chinese Journal of Pharmacovigilance
关键词
注射用头孢哌酮钠/舒巴坦钠
不良反应
cefoperazone sodium and sulbactam sodium for injection
Adverse Drug Reaction（ADR）
